Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
8Customers
3Debt Items
4Related Chains
Source-Backed Evidence Depth
Vericel Corporation (VCEL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
14Total relationships
5Distinct source URLs
9High confidence
0.821Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Vericel Corporation Suppliers
Ticker
Name
Confidence
Evidence
ALLCARE-PLUS-PHARMACY-INC
ALLCARE-PLUS-PHARMACY-INC
90%
The Company contracts with two specialty pharmacies, Orsini Pharmaceutical Services, Inc. ("Orsini") and AllCare Plus Pharmacy, Inc. ("AllCare") to distribute MACI in a manner in which the Company re…
Reciprocal relationship from MDWD graph: Reciprocal relationship from VCEL graph: Reciprocal relationship from MDWD graph: Reciprocal relationship from VCEL graph: Reciprocal relationship from MDWD g…
Vericel Corporation Customers
Ticker
Name
Confidence
Evidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES
95%
USAspending awards from Department of Health and Human Services: $34,880,933 across 1 awards. 75A50126C00002 NON SURGICAL DEBRIDEMENT | Qwen corrected direction: Explicit government contract awards f…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS
95%
USAspending awards from Department of Veterans Affairs: $573,425 across 9 awards. 36C25226P0376 IMPLANT; 36C25926P0377 PROS KNEE CARTILAGE DEFECTS; 36C25926P0334 PROS IMPLANTS | Qwen corrected direct…
ALLCARE-PLUS-PHARMACY-INC
ALLCARE-PLUS-PHARMACY-INC
85%
tical Services, Inc. (“Orsini”) and AllCare Plus Pharmacy, Inc. (“AllCare”) to distribute MACI in a manner in which the Company retains the credit and collection risk from the end customer. The Compa…
DMS-PHARMACEUTICAL-GROUP-INC
DMS-PHARMACEUTICAL-GROUP-INC
85%
In addition, the Company sells MACI directly to hospitals pursuant to an agreed upon purchase order and to a distributor, DMS Pharmaceutical Group, Inc. ("DMS") at a contracted rate for the treatment…
Reciprocal relationship from MDWD graph: Reciprocal relationship from VCEL graph: Reciprocal relationship from MDWD graph: Reciprocal relationship from VCEL graph: Reciprocal relationship from MDWD g…
ew manufacturing facility in Burlington, Massachusetts, the ability to sustain profitability, contributions to adjusted EBITDA, the expected target surgeon audience, potential fluctuations in sales a…
INSIDER-TRADING-COMPLIANCE-OFFICER-VERICEL-CORPO
INSIDER-TRADING-COMPLIANCE-OFFICER-VERICEL-CORPO
62%
Officer. G. Is This Insider Trading Policy Subject to Modification? The Company may at any time change this Insider Trading Policy or adopt such other policies or procedures which it considers approp…
OPERATIONS-OVERVIEW-VERICEL-CORPORATION
OPERATIONS-OVERVIEW-VERICEL-CORPORATION
62%
istent with what is reported on the consolidated statement of operations, for purposes of assessing performance, making operating decisions, allocating resources, and planning and forecasting for fut…
Vericel Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
VCEL-DEBT
Debt stack $13.2M
90%
Market cache reports total debt of $13.2M.
VCEL-DEBT-13307
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2017-12-31.
VCEL-DEBT-13306
Warrants outstanding: 4.27
90%
xbrl warrant detail from xbrl 2020-12-31.
Vericel Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Vericel Corporation.
Vericel Corporation Ownership
Holder
Name
Confidence
Evidence
VCEL-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 282 tracked holders.
